| Literature DB >> 32090021 |
Justyna Stefanowicz-Hajduk1, J Renata Ochocka1.
Abstract
Real-time cell analysis (RTCA) is a technique based on impedance and microsensor electrodes. RTCA system allows label-free, real-time, and continuous monitoring of cell adhesion, morphology, and rate of cell proliferation. The system offers a wide range of applications, mainly in toxicological studies, new drug screening, and microbiology. Here, we describe the usefulness of the system in different applications and compare this technology with conventional endpoint assays based on tetrazolium salts. We present advantages and disadvantages of the system and endpoint methods and their limitations in cytotoxicity investigations.Entities:
Keywords: Cell index; Impedance; Microsensor electrodes; RTCA; Tetrazolium salts
Year: 2020 PMID: 32090021 PMCID: PMC7025972 DOI: 10.1016/j.toxrep.2020.02.002
Source DB: PubMed Journal: Toxicol Rep ISSN: 2214-7500
Fig. 1The effect of different compounds on HeLa cells in the RTCA system. The cytostatic activity is presented by vinblastine at concentrations of 0.1–30.0 nM (A); the cytotoxic activity is presented by fraction of Kalanchoe daigremontiana at concentrations of 2.0–150.0 μg/mL (B). The presented results come from the authors own research.
Application examples of the real-time label-free RTCA system.
| Category | Example | Cell line | Kind of study | Refs |
|---|---|---|---|---|
| human breast cancer cells MCF-7 and MDA-MB-231 | cytotoxicity study | [ | ||
| human cervical cancer cells HeLa and breast cancer cells MDA-MB-231 | cytotoxicity study | [ | ||
| sarcoma cells (fibrosarcoma HT1080, liposarcoma SW872, T778, MLS-402, synovial sarcoma SW982, SYO1, 1273, malignant fibrous histiocytoma U2197), primary human fibroblasts | cytotoxicity study | [ | ||
| normal human fibroblasts | cytotoxicity study | [ | ||
| human dental pulp stem cells | cytotoxicity study | [ | ||
| plant metabolites | quercetin | human nasopharyngeal carcinoma cells | cytotoxicity study | [ |
| epigallocatechin gallate | human triple-negative breast cancer cells Hs578T | cytotoxicity study | [ | |
| apigenin, luteolin | human breast cancer cells MCF-7 | cell migration analysis | [ | |
| cardamonin | neonatal rat cardiomyocytes | cardiotoxicity study | [ | |
| icariside II | human melanoma cells A375 and SK-MEL-5 | cytotoxicity study | [ | |
| pennogenyl derivatives | human cervical cancer cells HeLa | cytotoxicity study | [ | |
| ginsenoside Rg1 | mouse cultured astrocytes | cytotoxicity study | [ | |
| chelidonine, homochelidonine | human lung adenocarcinoma A549 | cytotoxicity study | [ | |
| moschamine | human glioblastoma cells U251MG, T98 G, MRC5, HFL1 | cytotoxicity study | [ | |
| α-chaconine, α-solanine | human endometrial cells RL95-2 | estimation of the optimal cell density and time for the compounds addition | [ | |
| securinine | human cervical cancer cells HeLa | cytotoxicity study | [ | |
| 22 Amaryllidaceae alkaloids (e.g. haemanthamine, lycorine, haemanthidine) | 17 different human cell lines | screening of cytotoxic activity | [ | |
| cisplatin, paclitaxel, carboplatin, gemcitabine, topotecan, etoposide | human ovarian cancer cells A2780 | studies on antiproliferative effects | [ | |
| cisplatin, paclitaxel as nanodrugs | human breast cancer cells MDA-MB-231, MCF-7 | studies on antiproliferative effects | [ | |
| carboplatin, cyclophosphamide, docetaxel, etoposide, 5-fluorouracil, idarubicin, irinotecan, vinblastine, vinorelbine, dasatinib, daunorubicin, doxorubicin, epirubicin, imatinib, sorafenib, sunitinib | human hepatocellular carcinoma cells HepG2, mouse neuroblastoma ND7/23, mouse cardiomyocytes and fibroblasts | comparison of RTCA results for different drugs, determination of RTCA conditions for different cellular models | [ | |
| 5-fluorouracil, oxaliplatin | human colorectal carcinoma cells HCT116 | studies on sensitivity of the modified cells to the drugs | [ | |
| etoposide | human cardiomyocytes | cardiotoxicity study | [ | |
| vinblastine sulfate | human cervical cancer cells HeLa, human breast cancer cells MCF-7 | study on regeneration of RTCA plates | [ | |
| antineoplastic | motesanib | human colorectal cancer cells HT29 | study on limiting of the drug side effects | [ |
| cardiac | isoproterenol, carbachol, terfenadine, sotalol, ouabain | iPS cell-derived cardiomyocytes (iPS-CMs) and primary cardiomyocytes | study on cardiotoxic side effects of the drugs | [ |
| antiviral | acyclovir, foscarnet, ganciclovir | African green monkey kidney (Vero) cells, human fibroblasts | study on reducing the pathogenic viral effects in the cells | [ |
| ribavirin | African green monkey kidney (Vero) cells | study on reducing the pathogenic viral effects in the cells | [ | |
| immune-checkpoint inhibitors | nivolumab, pembrolizumab | patient-derived tumor organoids - lung cells with peripheral blood mononuclear cells (PBMCs) | cytotoxicity study | [ |
| drug delivery systems | emulsions, liposomes, lecithin dispersions | normal human kidney embryonic cells HEK 293 | cytotoxicity study | [ |
| drug formulation additives | sorbitol, lactate, sodium hydroxide | human cervical cancer cells HeLa | limitations in the use of RTCA system | [ |
| biodiesel and diesel blends | human hepatocellular carcinoma cells HepG2 | cytotoxicity study | [ | |
| inorganic | inorganic nanomaterials:Ag0, Al2O3, CeO2, Fe0, Fe2O3, HfO2, Mn2O3, SiO2, TiO2, ZnO, ZrO2 | human bronchial epithelial cells (16HBE14o-) | cytotoxicity study | [ |
| As (III) adsorbed onto CeO2 nanoparticles | human bronchial epithelial cells (16HBE14o-) | cytotoxicity study | [ | |
| pesticides | bromoxynil, chloroxynil, ioxynil | human liver carcinoma cells HepG2, kidney epithelial cells HEK 293T | cytotoxicity study | [ |
| DDT | mouse fibroblasts | cytotoxicity study | [ | |
| endocrine disruptors/anti-androgenic effect | bisphenol A | mouse Sertoli cells TM4 | cytotoxicity study | [ |
| cypermethrin | mouse Sertoli cells TM4 | cytotoxicity study | [ | |
| DEHP | human embryonic stem cells H9-hESCs | cytotoxicity study | [ | |
| African swine fever virus | African green monkey kidney fibroblast-like cells COS-1 | study on CPE | [ | |
| human enterovirus HEV71 | human rhabdomyosarcoma (RD) cells | study on CPE | [ | |
| herpes simplex virus, human cytomegalovirus | African green monkey kidney (Vero) cells, human fibroblasts | study on CPE and antiviral activity of drugs | [ | |
| chikungunya virus | African green monkey kidney (Vero) cells | study on CPE and antiviral activity of ribavirin | [ | |
| bacteria | mouse adrenal tumor cells, hamster ovary cells, intestine epithelial cells, mouse adrenal gland cells | monitoring of CT-mediated cytotoxicity | [ | |
| human skin fibroblasts HS27 | detection of the bacterial toxins from stool | [ |
Studies showing limitations in the use of RTCA system.
Fig. 2Calculation of IC50 value of vinblastine in HeLa cells based on sigmoidal dose response and area under curve in a time period vs concentration. The presented results come from the authors own research. R2 - the coefficient of determination.
Fig. 3The RTCA proliferation curves of HeLa cells in different densities. The presented results come from the authors own research.
The comparison of tetrazolium salt assays and RTCA system.
| Cytotoxicity assays | ||
|---|---|---|
| Tetrazolium salt assays | RTCA system | |
| Kind of cells | Adherent and suspension | Mostly adherent (suspension cell lines after pre-coating of the plate bottom) |
| Monitoring of cells | Under a microscope at selected time points | Real time and continuous |
| Obtain results | At one selected time point | At every time point of the experiment |
| Labeling reagent | Tetrazolium salts | No reagents |
| Detection principles | Spectrophotometric measuring absorbance | Recording the electrical impedance from the arrayed gold microchips covered the bottom of RTCA plates. Changes in impedance values reflect changes in cellular physiology and proliferation. CI - the basic obtained parameter |
| Contamination with assay reagent | Yes | No |
| Use of cells after experiment | No possibility to use | Use of cells for other assays (western blotting, imaging, |
| Optimization of cell density prior to experiment | Required | Required |
| Cost | Low cost | Costly |
| Use of plates | Disposable and single use | Disposable and single use, but possible regeneration and re-use |
| Applications | Cytotoxicity test of natural and synthetic compounds, drugs, plant extracts | Monitoring of cell adhesion, viability, and proliferation rate Cytotoxicity test of natural and synthetic compounds, drugs, plant extracts Assessment of cell migration and invasion Measuring of cardiomyocyte contractility and viability Differentiating cytostatic from cytotoxic effect of drugs RTCA proliferation profiles are useful in study of mechanism action of new drugs by comparison with profiles of well-known drugs |
| Limitations of application with | Colored compounds Compounds that interfere with tetrazolium reagents (e.g. antioxidants) | Drugs with electroactive additives Less adherent and suspension cell lines |